Form EFFECT Akari Therapeutics Plc
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 13, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FEWEST AMERICANS LIVING PAYCHECK TO PAYCHECK IN FIVE YEARS, BUT DEBT.COM SURVEY REVEALS A HIDDEN FINANCIAL ANXIETY
- CanCambria Energy Provides an Update on Its Shallow High-Impact Oil Play in Southern Hungary, Highlighting Nearby Producing Oil Fields, Increasing Industry Activity and Ten Identified Oil Field Target
- Valion Bio Advances Integrated Biodefense and Immunology Platform Through Continued Government Engagement, Domestic Manufacturing and Oncology Expansion
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
